David Shade

4.7k total citations · 1 hit paper
53 papers, 2.6k citations indexed

About

David Shade is a scholar working on Psychiatry and Mental health, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, David Shade has authored 53 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Psychiatry and Mental health, 15 papers in Pulmonary and Respiratory Medicine and 14 papers in Physiology. Recurrent topics in David Shade's work include Dementia and Cognitive Impairment Research (15 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers) and Asthma and respiratory diseases (11 papers). David Shade is often cited by papers focused on Dementia and Cognitive Impairment Research (15 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers) and Asthma and respiratory diseases (11 papers). David Shade collaborates with scholars based in United States, Canada and Australia. David Shade's co-authors include Robert A. Wise, Charles Wiener, Gerard J. Criner, Frank C. Sciurba, Shing M. Lee, William A. Slivka, Lea T. Drye, Anne E. Dixon, Anton P. Porsteinsson and Zab Mohsenifar and has published in prestigious journals such as New England Journal of Medicine, JAMA and Nature Medicine.

In The Last Decade

David Shade

53 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Citalopram on Agitation in Alzheimer Disease

2014 353 citations Anton P. Porsteinsson, Lea T. Drye et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Shade United States	27	1.0k	692	558	261	235	53	2.6k
Eileen G. Collins United States	29	991 1.0×	472 0.7×	266 0.5×	162 0.6×	104 0.4×	135	3.1k
Myron Yaster United States	44	376 0.4×	828 1.2×	243 0.4×	232 0.9×	263 1.1×	152	5.5k
Henry C. Weinstein Netherlands	25	277 0.3×	472 0.7×	652 1.2×	334 1.3×	522 2.2×	80	2.9k
P. Schmucker Germany	31	543 0.5×	209 0.3×	325 0.6×	426 1.6×	74 0.3×	134	3.1k
Paul R. Gallagher United States	36	831 0.8×	1.1k 1.5×	271 0.5×	161 0.6×	106 0.5×	98	3.7k
Paul Kudlow Canada	13	902 0.9×	199 0.3×	343 0.6×	276 1.1×	398 1.7×	25	2.9k
Bent Indredavik Norway	36	587 0.6×	249 0.4×	934 1.7×	109 0.4×	909 3.9×	95	4.5k
Hannu Kokki Finland	36	269 0.3×	336 0.5×	236 0.4×	497 1.9×	82 0.3×	184	3.9k
Jan Brøgger Norway	24	428 0.4×	357 0.5×	433 0.8×	49 0.2×	249 1.1×	51	1.8k
Giuseppe Zuccalà Italy	33	394 0.4×	469 0.7×	722 1.3×	114 0.4×	234 1.0×	113	3.6k

Countries citing papers authored by David Shade

Since Specialization

Citations

This map shows the geographic impact of David Shade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Shade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Shade more than expected).

Fields of papers citing papers by David Shade

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Shade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Shade. The network helps show where David Shade may publish in the future.

Co-authorship network of co-authors of David Shade

This figure shows the co-authorship network connecting the top 25 collaborators of David Shade. A scholar is included among the top collaborators of David Shade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Shade. David Shade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rajji, Tarek K., Sheriza Baksh, David Shade, et al.. (2025). Escitalopram for agitation in Alzheimer’s dementia: a randomized controlled phase 3 trial. Nature Medicine. 31(5). 1586–1591. 2 indexed citations

Rajji, Tarek K., Sheriza Baksh, David Shade, et al.. (2024). Escitalopram for Agitation in Alzheimer’s Dementia. Alzheimer s & Dementia. 20(S6). 1 indexed citations

Perin, Jamie, Alden L. Gross, David Shade, et al.. (2024). Adverse effects of methylphenidate for apathy in patients with Alzheimer's disease (ADMET2 trial). International Journal of Geriatric Psychiatry. 39(6). e6108–e6108. 1 indexed citations

Tumati, Shankar, Paul B. Rosenberg, Alan J. Lerner, et al.. (2024). Measuring clinically relevant change in apathy symptoms in ADMET and ADMET 2. International Psychogeriatrics. 36(12). 1232–1244. 2 indexed citations

Perin, Jamie, Nathan Herrmann, Olga Brawman‐Mintzer, et al.. (2023). Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study. Alzheimer s & Dementia Translational Research & Clinical Interventions. 9(3). e12403–e12403. 1 indexed citations

Appel, Lawrence J., Erin D. Michos, Christine Mitchell, et al.. (2020). The Effects of Four Doses of Vitamin D Supplements on Falls in Older Adults. Annals of Internal Medicine. 174(2). 145–156. 49 indexed citations

Barber, Matthew D., Linda Brubaker, Ingrid Nygaard, et al.. (2019). Pain and activity after vaginal reconstructive surgery for pelvic organ prolapse and stress urinary incontinence. American Journal of Obstetrics and Gynecology. 221(3). 233.e1–233.e16. 18 indexed citations

Ehrhardt, Stephan, Anton P. Porsteinsson, Cynthia A. Munro, et al.. (2019). Escitalopram for agitation in Alzheimer's disease (S‐CitAD): Methods and design of an investigator‐initiated, randomized, controlled, multicenter clinical trial. Alzheimer s & Dementia. 15(11). 1427–1436. 34 indexed citations

Charu, Vivek, Paul A. Rosenberg, Lon S. Schneider, et al.. (2017). Characterizing Highly Benefited Patients in Randomized Clinical Trials. The International Journal of Biostatistics. 13(1). 4 indexed citations

10.

Kaminsky, David A., Lucy Lu Wang, Jason H. T. Bates, et al.. (2017). Fluctuation Analysis of Peak Expiratory Flow and Its Association with Treatment Failure in Asthma. American Journal of Respiratory and Critical Care Medicine. 195(8). 993–999. 18 indexed citations

11.

Weiss, Clifford R., Olaguoke Akinwande, Lawrence J. Cheskin, et al.. (2017). Clinical Safety of Bariatric Arterial Embolization: Preliminary Results of the BEAT Obesity Trial. Radiology. 283(2). 598–608. 41 indexed citations

12.

Akil, Ayman, Robert R. Bies, Bruce G. Pollock, et al.. (2015). A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer’s disease patients with agitation. Journal of Pharmacokinetics and Pharmacodynamics. 43(1). 99–109. 16 indexed citations

13.

Lambert, Allison, Enid Neptune, Robert H. Brown, et al.. (2015). Angiotensin Receptor Blockade Treatment for COPD: Phase II Trial. CHEST Journal. 148(4). 744A–744A. 3 indexed citations

14.

Peters, Matthew E., Lea T. Drye, Davangere P. Devanand, et al.. (2015). Citalopram for the Treatment of Agitation in Alzheimer Dementia. Journal of Geriatric Psychiatry and Neurology. 29(2). 59–64. 9 indexed citations

15.

Weintraub, Daniel, Lea T. Drye, Anton P. Porsteinsson, et al.. (2015). Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease. American Journal of Geriatric Psychiatry. 23(11). 1127–1133. 19 indexed citations

16.

Lang, Jason E., Allen J. Dozor, Janet T. Holbrook, et al.. (2013). Biologic Mechanisms of Environmental Tobacco Smoke in Children with Poorly Controlled Asthma: Results from a Multicenter Clinical Trial. The Journal of Allergy and Clinical Immunology In Practice. 1(2). 172–180.e2. 31 indexed citations

17.

Lang, Jason E., Jobayer Hossain, Anne E. Dixon, et al.. (2011). Does Age Impact the Obese Asthma Phenotype?. CHEST Journal. 140(6). 1524–1533. 61 indexed citations

18.

Simpson, Crystal F., N.M. Punjabi, Luke Wolfenden, et al.. (2005). Relationship Between Lung Function and Physical Performance in Disabled Older Women. The Journals of Gerontology Series A. 60(3). 350–354. 22 indexed citations

19.

Mastronarde, John G., Robert A. Wise, Steven M. Scharf, David Shade, & Christopher O. Olopade. (2004). Sleep Quality in Asthma: Results of a Large Prospective Clinical Trial. CHEST Journal. 126(4). 706S–706S. 1 indexed citations

20.

Sciurba, Frank C., Gerard J. Criner, Shing M. Lee, et al.. (2003). Six-Minute Walk Distance in Chronic Obstructive Pulmonary Disease: Reproducibility and Effect of Walking Course Layout and Length. American Journal of Respiratory and Critical Care Medicine. 167(11). 1522–1527. 300 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact